Brief: Qualigen Therapeutics, Inc. Provides Update On Product Development Priorities And Reports Second Quarter And Six Month 2021 Financial Results
17/08/2021 13:54
Aug 17 (Reuters) - Qualigen Therapeutics Inc QLGN.O :
* QUALIGEN THERAPEUTICS, INC. PROVIDES UPDATE ON PRODUCT
DEVELOPMENT PRIORITIES AND REPORTS SECOND QUARTER AND SIX MONTH
2021 FINANCIAL RESULTS
* Q2 REVENUE ROSE 24 PERCENT TO $1.1 MILLION
* Q2 LOSS PER SHARE $0.18
* AS OF JUNE 30, 2021, CO HAD $15.2 MILLION OF CASH AND CASH
EQUIVALENTS
Source text for Eikon: ID:nGNX4w1LRT
Further company coverage: QLGN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aixcrypto Holdings
See all newsBrief: Aixcrypto - Enters Common Shares Purchase Agreement With Gold King Arthur Holding - SEC Filing
Chief Executive Officer And Director
Brief: Aixcrypto Holdings - Enters Note Purchase Agreement With CABG Acquisition Corp On May 12, 2026 - SEC Filing
Brief: Aixcrypto Holdings Reports First Quarter 2026 Results
AIxCrypto Q1 net loss widens as expenses rise